Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, has started shipping its LTV2 2200 ventilators as part of its contract with the U.S. Department of Health and Human Services (HHS).

The U.S. Food and Drug Administration granted an Emergency Use Authorization to distribute the LTV2 2200.in the United States while the company pursues a 510(k) submission. HHS awarded Vyaire Medical a $407.9 million contract to produce 22,000 ventilators for the U.S. National Strategic Stockpile by June 29.

The LTV2 2200 ventilator, already in use in Japan , is latest an iteration in the popular LTV series of ventilators that are designed to be lightweight and portable in the healthcare setting.

“Vyaire Medical’s sole business is making and servicing respiratory devices and we are well-positioned to deliver much-needed equipment to our frontline responders as they treat patients suffering breathing difficulties as a result of the SARS-CoV-2 novel coronavirus,” said CEO Gaurav Agarwal. “Our team accelerated production and delivery of ventilators back in February, and we are grateful for the partnership with the Department of Health and Human Services to further expand production and speed the delivery of this essential medical equipment where it is most needed.”

Beginning in February, Vyaire Medical has taken numerous steps to meet the growing demand for ventilators and other related respiratory equipment, including hiring additional workers to add manufacturing shifts at its facility in Palm Springs, CA. The company also focused engineering resources on high-priority, high-demand equipment and consumables and began deploying ventilators as quickly as they were made to the regions that need them most.

“We took swift and decisive action as a result of this evolving pandemic in order to meet the expected surge in demand for ventilation equipment,” Agarwal said. “Our goal was to increase output as quickly as possible. We have been in close contact with government officials and healthcare experts at the federal and state level since this outbreak began, and we are grateful for their support. This HHS award to supply ventilators for the U.S. Strategic National Stockpile   allows us to further dramatically expand our production capabilities to help satisfy the intensifying need for respiratory care equipment.”

For more information about Vyaire’s response to the COVID-19 crisis, visit the company’s COVID-19 Response Center at https://www.vyaire.com/Covid-19.